With seven years of experience, at WHC we offer pharmaceutical drug development and contract research services for our clients. These services are customized based on clients’ schedule and costs, while assuring high quality standards. We possess a history of profitable collaborations with other organizations, all of which have resulted to be mutually beneficial in many aspects. Recent example such collaboration includes development and ANDA filling of (F2F)/para IV generic product and creation of technological platform for medicinal nanoparticles and their characterization.
Our capabilities to provide development and evaluation of products for the clients also includes pre-formulation stability study, pilot bioequivalence study, analytical development including validation, technology transfer of both manufacturing and analytical processes, and support to regulatory dossier. With the above R&D services from WHC, pharmaceutical companies can minimize the time required from pre-clinical trials to market launch of a drug.
We offer services right from identifying and approving the adequate raw material and packing material for vendors, to completing the dossier as per the prescribed Common Technical Document (CTD) format for regulatory purposes.
Critical phases in the discovery, development, and manufacture of pharmaceuticals – such as development and validation – facilitate to ascertain the identity, purity, potency and performance of drugs. We offer development and validation services for high-quality evaluation of emerging drugs by our highly qualified scientists in organic synthesis. We also deliver enantiomeric pure, intermediate and active pharmaceutical ingredients.
We offer process validation and troubleshooting services to verify the quality and result of a process as compared to predetermined specifications, allowing pharmaceutical companies to vet the effect or performance of their products. We work to reduce costs and maximize yields through our special product/process development program, which also improves bioavailability and bioequivalence.
Our services help you in completing various regulatory, legal and documentation processes, which vary across geographies, such as completing dossiers in CTD format.
Due to our advanced technology in this department, we have expertise in formulating tablets, capsules, pellets, granules, sachet, MUPS of immediate & sustained release application that have met the first order reaction kinetics and have a delayed release by oral dosage.
Stability testing is essential to determine how a drug or its constituents respond to or vary with environmental factors such as temperature, light exposure, and humidity. For this, we offer services such as screening a second Active Pharmaceutical Ingredient (API) for your formulation.